ST. JOSEPH, Mich., Feb. 10 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that Becker Medical Library at Washington University in St. Louis has licensed MetaCore. The Becker Medical Library Bioinformatics@Becker program is a university wide resource which provides bioinformatics support for researchers and students. MetaCore is an easy to use data mining tool that provides users with fast easy access to up to date pertinent pathway information. Researchers can run simple searches as well as very specific Boolean queries and have answers in seconds or minutes rather than weeks and months using traditional methods. MetaCore can also be used for pathway analysis of all kinds of experimental data from gene expression, micro RNA to assay data as well as biomarker studies
"Becker Medical Library at Washington University in St. Louis is an important customer for GeneGo as we build up the number of libraries using GeneGo products," said Julie Bryant, GeneGo's VP of Business development. "Libraries are the heart of most academic centers and an excellent resource for PI's, researchers and students where systems biology comes together with all types of experimental data, biologists, chemists and pharmacologists and therapeutic focuses."
About GeneGo, Inc.
GeneGo, Inc. develops systems biology technology such as compound based pathway analysis, cheminformatics & bioinformatics software for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 5.2(TM), assists pharmaceutical scientists in the areas of target selection and validation, data mining in biology, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 5.2(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore.
For more information, please visit the company's web site at www.genego.com.
Related medicine news :1
. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington2
. Childrens Hospitals in Washington to Lobby Congress to Reauthorize SCHIP Now3
. Medicare Cuts to Physicians Will Harm Washington Seniors4
. Staying sharp in Washington, D.C.5
. Cardiac Science Named to Deloittes Technology Fast 50 for Washington State6
. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2007 Washington State Technology Fast 50 for 4th Time in Past 6 Years7
. Washington Comes Together to Promote Smoking Cessation8
. A Breath of Fresh Air From Washington: Senate Passes Historic Asbestos Ban9
. Washington Capitals to Visit Patients at Childrens National Medical Center, Announce Launch of Initiative to Fight Pediatric Cancer10
. Are We Ready? Washington Hospital Center Sets Precedents in Preparedness for 9/11-Style Attacks11
. 14,000 Public Health Experts to Convene at American Public Health Association Annual Meeting in Washington, D.C.